StockClub

ARTV

ARTVArtiva Biotherapeutics, Inc.$ --
Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics, Inc.

ARTV

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY -
Operating Income
-24M USD
YoY -10.2%
Net Income
-24M USD
YoY -15.8%
EPS
-0.95$
YoY -14.5%

Revenue

$0
FY2024 Q2$251,000
$251,000
Q2
FY2024 Q3$251,000
$251,000
Q3
FY2024 Q4$251,000
$251,000
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
FY2026 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-23.5M
FY2024 Q2$-31.8M
$-31.8M
Q2
FY2024 Q3$-49.3M
$-49.3M
Q3
FY2024 Q4$-58.5M
$-58.5M
Q4
FY2025 Q1$-20.3M
$-20.3M
Q1
FY2025 Q2$-41.6M
$-41.6M
Q2
FY2025 Q3$-63.1M
$-63.1M
Q3
FY2025 Q4$-83.9M
$-83.9M
Q4
FY2026 Q1$-23.5M
$-23.5M
Q1
Actual
$-3.2M (-15.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$2M
FY2021
$2M
FY2022
Actual:$4.9M
FY2022
$4.9M
FY2023
Actual:$33.5M
FY2023
$33.5M
FY2024MISS
Actual:$251,000
Est:$275,333
FY2024MISS
$251,000
FY2025IN-LINE
Actual:$0
Est:$0
FY2025IN-LINE
$0

Analyst Estimates